Abstract:Emerging evidence suggests that GSK3β, a redox-sensitive transducer downstream of insulin signaling, acts as a convergent point for myriad pathways implicated in kidney injury, repair, and regeneration. However, its role in diabetic kidney disease remains controversial. In cultured glomerular podocytes, exposure to a milieu of type 2 diabetes elicited prominent signs of podocyte injury and degeneration, marked by loss of homeostatic marker proteins like synaptopodin, actin cytoskeleton disruption, oxidative stress and apoptosis, and stress-induced premature senescence, as shown by increased staining for senescence-associated β-galactosidase activity, amplified formation of γH2AX foci, and elevated expression of mediators of senescence signaling, like p21 and p16INK4A. These degenerative changes coincided with GSK3β hyperactivity, as evidenced by GSK3β overexpression and reduced inhibitory phosphorylation of GSK3β, and were averted by tideglusib, a highly-selective small molecule inhibitor of GSK3β. In agreement, post-hoc analysis of a publicly-available glomerular transcriptomics dataset from patients with type 2 diabetic nephropathy revealed that the curated diabetic nephropathy-related gene set was enriched in high GSK3β expression group. Mechanistically, GSK3β-modulated nuclear factor Nrf2 signaling is involved in diabetic podocytopathy, because GSK3β knockdown reinforced Nrf2 antioxidant response and suppressed oxidative stress, resulting in an improvement in podocyte injury and senescence. Conversely, ectopic expression of the constitutively active mutant of GSK3β impaired Nrf2 antioxidant response and augmented oxidative stress, culminating in an exacerbated diabetic podocyte injury and senescence. Moreover, IRS-1 was found to be a cognate substrate of GSK3β for phosphorylation at IRS-1S332, which negatively regulates IRS-1 activity. GSK3β hyperactivity promoted IRS-1 phosphorylation, denoting a desensitized insulin signaling. Consistently, in vivo in db/db mice with diabetic nephropathy, GSK3β was hyperactive in glomerular podocytes, associated with IRS-1 hyperphosphorylation, impaired Nrf2 response and premature senescence. Our finding suggests that GSK3β is likely a novel therapeutic target for treating type 2 diabetic glomerular injury.

PKC-α Triggers EGFR Ubiquitination, Endocytosis and ERK Activation in Podocytes Stimulated with High Glucose

Inhibiting PKCβ2 protects HK-2 cells against meglumine diatrizoate and AGEs-induced apoptosis and autophagy.

Tripterygium glycoside protects diabetic kidney disease mouse serum-induced podocyte injury by upregulating autophagy and downregulating β-arrestin-1.

PKCδ Promotes High Glucose Induced Renal Tubular Oxidative Damage Via Regulating Activation and Translocation of P66shc

PKC-beta1 Mediates Glucose-Induced Akt Activation and TGF-beta1 Upregulation in Mesangial Cells.

The Redox-Sensitive GSK3β is a Key Regulator of Glomerular Podocyte Injury in Type 2 Diabetic Kidney Disease

P2X7R/AKT/mTOR Signaling Mediates High Glucose-Induced Decrease in Podocyte Autophagy

High Glucose-Induced Podocyte Injury Involves Activation of Mammalian Target of Rapamycin (Mtor)-Induced Endoplasmic Reticulum (ER) Stress.

Rac1/PAK1 Signaling Promotes Epithelial-Mesenchymal Transition of Podocytes in Vitro Via Triggering Β-Catenin Transcriptional Activity under High Glucose Conditions

Akt and RhoA Activation in Response to High Glucose Require Caveolin-1 Phosphorylation in Mesangial Cells

Role of Protein Kinase C in Advanced Glycation End Products-Induced Epithelial-Mesenchymal Transition in Renal Proximal Tubular Epithelial Cells

Ubiquitination and endoplasmic reticulum stress of renal intrinsic cells in hyperglycemia

The Roles of Connective Tissue Growth Factor and Integrin‐linked Kinase in High Glucose‐induced Phenotypic Alterations of Podocytes

p66Shc regulates podocyte autophagy in high glucose environment through the Notch-PTEN-PI3K/Akt/mTOR pathway

Cellular mechanisms in the development and progression of diabetic nephropathy: activation of the DAG-PKC-ERK pathway

Epigallocatechin-3-gallate Protects from High Glucose Induced Podocyte Apoptosis Via Suppressing Endoplasmic Reticulum Stress

The Activation of Extracellular Signal-Regulated Kinase is Responsible for Podocyte Injury

Growth associated protein 43 deficiency promotes podocyte injury by activating the calmodulin/calcineurin pathway under hyperglycemia

Protein Kinase C and Protein Kinase A Are Involved in the Protection of Recombinant Human Glucagon‐like Peptide‐1 on Glomeruli and Tubules in Diabetic Rats

Extracellular signal-regulated kinase is activated in podocytes from patients with diabetic nephropathy

Role of protein kinase C on the alteration of retinal endothelin-1 in streptozotocin-induced diabetic rats.